Hancock GE - Search Results

1

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.

Hancock GE, Speelman DJ, Frenchick PJ, Mineo-Kuhn MM, Baggs RB, Hahn DJ. Hancock GE, et al. Vaccine. 1995 Mar;13(4):391-400. doi: 10.1016/0264-410x(95)98263-a. Vaccine. 1995. PMID: 7793137 Free article.

2

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

Hancock GE, Hahn DJ, Speelman DJ, Hildreth SW, Pillai S, McQueen K. Hancock GE, et al. Vaccine. 1994;12(3):267-74. doi: 10.1016/0264-410x(94)90204-6. Vaccine. 1994. PMID: 8165859

3

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.

Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, Cosco C. Hancock GE, et al. J Virol. 1996 Nov;70(11):7783-91. doi: 10.1128/JVI.70.11.7783-7791.1996. J Virol. 1996. PMID: 8892899 Free PMC article.

4

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus.

Hancock GE, Heers KM, Pryharski KS, Smith JD, Tiberio L. Hancock GE, et al. Vaccine. 2003 Oct 1;21(27-30):4348-58. doi: 10.1016/s0264-410x(03)00482-1. Vaccine. 2003. PMID: 14505917

5

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Tebbey PW, Scheuer CA, Peek JA, Zhu D, LaPierre NA, Green BA, Phillips ED, Ibraghimov AR, Eldridge JH, Hancock GE. Tebbey PW, et al. Among authors: hancock ge. Vaccine. 2000 Jun 1;18(24):2723-34. doi: 10.1016/s0264-410x(00)00058-x. Vaccine. 2000. PMID: 10781860

6

CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV).

Hancock GE, Heers KM, Smith JD, Scheuer CA, Ibraghimov AR, Pryharski KS. Hancock GE, et al. Vaccine. 2001 Sep 14;19(32):4874-82. doi: 10.1016/s0264-410x(01)00228-6. Vaccine. 2001. PMID: 11535341

7

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE. Elliott MB, et al. Among authors: hancock ge. Vaccine. 2007 Oct 10;25(41):7132-44. doi: 10.1016/j.vaccine.2007.07.065. Epub 2007 Aug 21. Vaccine. 2007. PMID: 17850933

8

QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus.

Hancock GE, Heers KM, Smith JD. Hancock GE, et al. Viral Immunol. 2000;13(4):503-9. doi: 10.1089/vim.2000.13.503. Viral Immunol. 2000. PMID: 11192297

9

The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12.

Hancock GE, Smith JD, Heers KM. Hancock GE, et al. Viral Immunol. 2000;13(1):57-72. doi: 10.1089/vim.2000.13.57. Viral Immunol. 2000. PMID: 10733169

10

A novel and effective intranasal immunization strategy for respiratory syncytial virus.

Tebbey PW, Unczur CA, LaPierre NA, Hancock GE. Tebbey PW, et al. Among authors: hancock ge. Viral Immunol. 1999;12(1):41-5. doi: 10.1089/vim.1999.12.41. Viral Immunol. 1999. PMID: 10333241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters